Eleonora M. Lad

ORCID: 0000-0001-8435-521X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Imaging and Analysis
  • Retinal Diseases and Treatments
  • Glaucoma and retinal disorders
  • Retinal and Optic Conditions
  • Retinopathy of Prematurity Studies
  • Retinal Development and Disorders
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Ophthalmology and Visual Impairment Studies
  • Neonatal Respiratory Health Research
  • Retinal and Macular Surgery
  • Functional Brain Connectivity Studies
  • Optical Coherence Tomography Applications
  • Advanced Neuroimaging Techniques and Applications
  • Medical History and Innovations
  • Spine and Intervertebral Disc Pathology
  • Spinal Fractures and Fixation Techniques
  • History of Medical Practice
  • Laser Applications in Dentistry and Medicine
  • Neonatal and fetal brain pathology
  • History of Medicine Studies
  • Visual perception and processing mechanisms
  • Neonatal Health and Biochemistry
  • Vascular Malformations Diagnosis and Treatment
  • Aging and Gerontology Research
  • Ophthalmology and Visual Health Research

Duke Medical Center
2015-2024

Duke University
2014-2024

Duke University Hospital
2016-2024

Durham Technical Community College
2023

Eye Center
2022

Ophthalmology Associates (United States)
2013

Stanford University
2007-2011

Menlo School
2008

Stanford Medicine
2007

Jeffrey S. Heier Eleonora M. Lad Frank G. Holz Philip J. Rosenfeld Robyn H. Guymer and 95 more David S. Boyer F Grossi Caroline R. Baumal Jean‐François Korobelnik Jason S. Slakter Nadia K. Waheed Ravi Metlapally Ian Pearce Nathan Steinle A Francone Allen Hu David R. Lally Pascal Deschatelets Cedric Francois Caleb Bliss Giovanni Staurenghi Jordi Monés Rishi P. Singh Ramiro Ribeiro Charles C. Wykoff Abosede O Cole Adam T. Gerstenblith Ajay Kotagiri Albert O. Edwards Alberto D Zambrano Alexander M. Eaton Alexander Rubowitz Alice T. Lyon Allen Chiang Allen C. Ho Allen Hu Amir Guerami Amr Dessouki André Corrêa Maia de Carvalho Andrés Emanuelli Andrew Chang Andrew N. Antoszyk A Francone Anita Prasad Armin Wolf Arshad M. Khanani Ashkan M. Abbey Asma Moulana Barbara Wihelm Bartosz L. Sikorski Baruch D. Kuppermann Benjamin Wolff Brian Jewart K. Brian Brian T. Chan-Kai Calvin E. Mein Carel B. Hoyng Carl C. Awh Carl Regillio Carlos Zeolite Caroline R. Baumal Catherine Creuzot‐Garcher Catherine Français Maury Charles C. Wykoff Charles K Newell Chirag Jhaveri Chris P. Lohmann Christiana Dinah Colin Ma Courtney Crawford D Wilkin Parke Daniel Lavinsky Daniel B. Roth Dante J. Pieramici Darius M. Moshfeghi Darrin Levin David A. Saperstein David M. Brown David Gaucher David R. Lally David Liao David Warren Brown Debra A. Goldstein Dennis M. Marcus Derek G. Chan Dilsher S. Dhoot Domingo Tacite Dominik Zalewski Edgar M. Espana Eleonora M. Lad Eric H. Souied Eric Suan Eva Eting Federico Furno Sola F. De Bats Francesco Bandello Francisco Gómez‐Ulla François Devin Frank G. Holz Fred K. Chen

10.1016/s0140-6736(23)01520-9 article EN The Lancet 2023-10-01

Outer retinal degenerations, including age-related macular degeneration (AMD), are characterized by photoreceptor and pigment epithelium (RPE) atrophy. In these blinding diseases, macrophages accumulate at atrophic sites, but their ontogeny niche specialization remain poorly understood, especially in humans. We uncovered a unique profile of microglia, marked galectin-3 upregulation, sites mouse models human AMD. disease models, conditional deletion microglia led to phagocytosis defects...

10.1084/jem.20231011 article EN cc-by-nc-sa The Journal of Experimental Medicine 2024-01-30

Inner retina in Alzheimer's Disease (AD) may experience neuroinflammation resulting atrophy. The objective of our study was to determine whether retinal GCIPL (ganglion cell-inner plexiform layer) or nerve fiber layer (NFL) thickness serve as noninvasive biomarkers diagnose AD. This cross-sectional case-control enrolled 15 mild cognitive impairment (MCI) patients, mild-moderate AD and 18 cognitively normal adults. NFL thicknesses on optical coherence tomography (OCT) were measured using Duke...

10.1371/journal.pone.0192646 article EN cc-by PLoS ONE 2018-02-08

To assess visual function outcomes to 48 weeks in patients with bilateral geographic atrophy (GA) secondary age-related macular degeneration included 2 interventional clinical trials: relationship baseline lesion size, by characteristic subgroups, and correlation of GA area.The Chroma Spectri studies (ClinicalTrials.gov identifiers, NCT02247479 NCT02247531, respectively) were identically designed phase 3, double-masked, multicenter, randomized, sham injection-controlled trials that evaluated...

10.1016/j.oret.2020.01.019 article EN cc-by-nc-nd Ophthalmology Retina 2020-01-31

Diabetic retinopathy (DR) is a leading cause of blindness in working-age adults and remains an important public health issue worldwide. Here we demonstrate that the expression stimulator interferon genes (STING) increased patients with DR animal models diabetic eye disease. STING has been previously shown to regulate cell senescence inflammation, key contributors development progression DR. To investigate mechanism whereby contributes pathogenesis DR, diabetes was induced STING-KO mice...

10.1172/jci.insight.168945 article EN cc-by JCI Insight 2023-06-21

<h3>Aims</h3> To determine the incidence of retinopathy prematurity (ROP) based upon a national database and to identify baseline characteristics, demographic information, comorbidities, surgical interventions. <h3>Methods</h3> The National Inpatient Sample, representative sample all US hospital discharges from 1997 2002, was queried for newborn infants with without ROP. Primary outcome variables included demographics, length stay (LOS), charges. Multivariate logistic regression used predict...

10.1136/bjo.2007.126201 article EN British Journal of Ophthalmology 2008-02-26

To evaluate the effect of select baseline characteristics on geographic atrophy (GA) progression in eyes receiving intravitreal pegcetacoplan or sham.Phase 2 multicenter, randomized, single-masked, sham-controlled trial.Patients with GA received 15 mg monthly every other month (EOM), sham injection EOM for 12 months. Primary efficacy endpoint was change lesion size (square root) from baseline. Post hoc analysis evaluated effects age; gender; size, focality, and location (extrafoveal vs...

10.1016/j.ajo.2021.02.031 article EN cc-by-nc-nd American Journal of Ophthalmology 2021-03-03

Purpose: The LIGHTSITE III study evaluated multiwavelength photobiomodulation (PBM) therapy in nonexudative (dry) AMD using the LumiThera Valeda ® Light Delivery System. Methods: is a randomized, controlled trial to assess safety and effectiveness of PBM dry AMD. Subjects were treated with (590, 660 850 nm) or Sham treatment delivered 9 treatments over 3-5 weeks every four months 24 months. assessed for efficacy outcomes. Data from 13-month analysis are presented this report. Results: A...

10.1097/iae.0000000000003980 article EN cc-by-nc-nd Retina 2023-11-08

Age-related macular degeneration (AMD) has recently been linked to cognitive impairment. We hypothesized that AMD modifies the brain aging trajectory, and we conducted a longitudinal diffusion MRI study on 40 participants (20 with 20 controls) reveal location, extent, dynamics of AMD-related changes. Voxel-based analyses at first visit identified reduced volume in cuneate gyrus, associated vision, temporal bilateral cingulate higher cognition memory. The second occurred 2 years after...

10.3390/biomedicines12010147 article EN cc-by Biomedicines 2024-01-10

The peripheral retina of the human eye offers a unique opportunity for assessment and monitoring ocular diseases. We have developed novel wide-field (>70°) optical coherence tomography system (WF-OCT) equipped with wavefront sensorless adaptive optics (WSAO) enhancing visualization smaller (<25°) targeted regions in retina. iterated WSAO algorithm at speed individual OCT B-scans (~20 ms) by using raw spectral interferograms to calculate optimization metric. Our approach 3 mm beam diameter...

10.1364/boe.8.000016 article EN cc-by Biomedical Optics Express 2016-12-02

Purpose: The purpose of this study was to evaluate baseline best corrected visual acuity (BCVA), full-field electroretinography (ERG), stimulus thresholds (FST), and their relationship with demographic clinical characteristics in the Rate Progression Usher syndrome type 2 (USH2A)-related Retinal Degeneration (RUSH2A) multicenter study. Methods: Participants had (USH2, N = 80) or autosomal recessive nonsyndromic retinitis pigmentosa (ARRP, 47) associated biallelic variants USH2A gene....

10.1167/tvst.9.11.9 article EN cc-by-nc-nd Translational Vision Science & Technology 2020-10-08
Coming Soon ...